Raymed Labs Limited was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities on Dehradun Road, Saharanpur, UP. The Company embarked on a new and exciting phase of its growth journey. As a widely operational pharmaceutical company, it proved excellence in the competitive ophthalmology industry with its robust marketing infrastructure across the geographies.Raymed created an integrated multitechnology capability to manufacture all types of formulations with innovative and advanced technologies focusing into Preservative free Ophthalmic dosage specially for Conjunctivitis and Glaucoma Patient care, Various other formulations have been converted from suspension to solution which helps in the effective absorption, penetration and better patience compliance.Highly skilled technicians operate multiple manufacturing facilities with the world class technology, having ultramodern equipment and machineries for manufacturing formulations in wide range of dosage forms. All are facilities are certified with WHOGMP, ISO 9001:2008 and various International accreditations like ANVISABrazil, NAFDACNigeria, FDBGhana, PMPBMalawi amongst others. Expanding with time the Company has a comprehensive range of over 80 products, Raymed is a trademark owner of ophthalmic solution (eye drops), antioxidant capsules and tablets.
Raymed Labs Share Price Today
As of 11 Nov 2025, Raymed Labs share price is ₹3.6. The stock opened at ₹3.6 and had closed at ₹3.6 the previous day. During today’s trading session, Raymed Labs share price moved between ₹3.65 and ₹3.65, with an average price for the day of ₹3.65. Over the last 52 weeks, the stock has recorded a low of ₹2.75 and a high of ₹3.65. In terms of performance, Raymed Labs share price has increased by 15.1% over the past six months and has increased by 39.31% over the last year.